Compounds containing oxazolidinone, triazole and macrolide groups in the treatment of mycobacterial infections

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.18, Iss.9, 2008-09, pp. : 1101-1105

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Developments on Drug Delivery Systems for the Treatment of Mycobacterial Infections

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 7, 2008-04 ,pp. : 579-591

Bentham Science Publishers

Access to resources Recommend Favorite

Ketolides: an emerging treatment for macrolide-resistant respiratory infections, focusing on S. pneumoniae

By Zhanel George G Hisanaga Tamiko Nichol Kim Wierzbowski Aleksandra Hoban Daryl J

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 2, 2003-11 ,pp. : 297-321

Informa Healthcare

Access to resources Recommend Favorite

Adjunctive Immunotherapy of Mycobacterial Infections

Current Pharmaceutical Design, Vol. 10, Iss. 26, 2004-10 ,pp. : 3297-3312

Bentham Science Publishers

Access to resources Recommend Favorite

Novel compounds for the treatment of varicella–zoster virus infections

By Visalli Robert J

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 3, 2004-03 ,pp. : 355-365

Informa Healthcare

Access to resources Recommend Favorite

Liposomes containing drugs for treatment of vaginal infections

By Pavelic Z. Skalko-Basnet N. Jalsenjak I.

European Journal of Pharmaceutical Sciences, Vol. 8, Iss. 4, 1999-08 ,pp. : 345-351

Elsevier

Access to resources Recommend Favorite